#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune haemolytic anaemia Corneal neovascularisation X-linked lymphoproliferative syndrome Fontan procedure Alveolar rhabdomyosarcoma Synovial sarcoma metastatic Hypophosphatasia Mitochondrial DNA depletion Epidermolysis bullosa Alagille syndrome Angiosarcoma metastatic Leber's congenital amaurosis Oesophageal adenocarcinoma stage II Hypocalcaemia PIK3CA-activated mutation More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Treatment Familial amyotrophic lateral sclerosis – Basic Information Cytokine release syndrome Osteosarcoma – Diagnostics Glycogen storage disease type V – Basic Information Synovial sarcoma recurrent – Life with Disease MELAS syndrome – Treatment Glomerulonephritis rapidly progressive – Life with Disease Alexander disease Glomerulonephritis membranous – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ocrelizumab Bms-986408 SILYMARIN Sparsentan A49 FOSMANOGEPIX OMTX705 89ZR-CED88004S Arrhenatherum Elatius SODIUM IBANDRONATE Nystatin Ixazomib Camonsertib Promazine Hydrochloride Mebeverine Hydrochloride IMMUNOSTEM Chlorhexidine Gluconate Paliperidone Doxecitine Rhh646 More therapies…

    Learn about Your Condition

    Breast proliferative changes Aphthous ulcer Alcohol abuse Adrenogenital syndrome Candida infection Leukoencephalopathy Muscle strain Laryngeal leukoplakia Tendon disorder Circulatory collapse Ejection fraction normal Glycogen storage disorder Bipolar I disorder Hepatic encephalopathy VEXAS syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Arteriosclerosis

  • Study on Aspirin’s Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    • Type 1 diabetes mellitus
    • Arteriosclerosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark

  • Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Arteriosclerosis
    Investigated Drugs:
    • Opium, Standardized Powdered
    • Colchicine
    • Tiemonium Methylsulphate
    The Netherlands

  • Inclisiran for Preventing Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

    Not recruiting

    1 1
    Investigated Diseases:
    • Arteriosclerosis
    Belgium

  • A study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Glucose Monohydrate
    • Sodium Chloride
    Germany
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!